| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CD138− plasma cell myeloma
|
Shuai, Wen
|
|
|
134 |
11 |
p. 906
|
artikel
|
| 2 |
Editorial Board
|
|
|
|
134 |
11 |
p. i
|
artikel
|
| 3 |
Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients
|
Swystun, Laura L.
|
|
|
134 |
11 |
p. 880-891
|
artikel
|
| 4 |
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
|
Zhang, Haijiao
|
|
|
134 |
11 |
p. 867-879
|
artikel
|
| 5 |
Illuminating neutrophilic myeloid neoplasms
|
Hasserjian, Robert P.
|
|
|
134 |
11 |
p. 846-848
|
artikel
|
| 6 |
Martin P, Bartlett NL, Blum KA, et al. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019;133(11):1201-1204.
|
|
|
|
134 |
11 |
p. 908
|
artikel
|
| 7 |
Natural history and cell of origin of TC F3-ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL
|
Bueno, Clara
|
|
|
134 |
11 |
p. 900-905
|
artikel
|
| 8 |
Pay attention to neutrophil inclusions in pediatric patients with thrombocytopenia
|
Iqbal, Nazia Tabassum
|
|
|
134 |
11 |
p. 907
|
artikel
|
| 9 |
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
|
Tam, Constantine S.
|
|
|
134 |
11 |
p. 851-859
|
artikel
|
| 10 |
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation
|
Battipaglia, Giorgia
|
|
|
134 |
11 |
p. 892-899
|
artikel
|
| 11 |
PTCY keeps on giving!
|
Radojcic, Vedran
|
|
|
134 |
11 |
p. 848-849
|
artikel
|
| 12 |
The CNS can be a safe space for CARs
|
Ramos, Carlos Almeida
|
|
|
134 |
11 |
p. 845-846
|
artikel
|
| 13 |
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
|
Frigault, Matthew J.
|
|
|
134 |
11 |
p. 860-866
|
artikel
|
Tijdschrift beschrijving